Published in Am J Cardiol on August 15, 2001
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2008) 5.27
European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int (2012) 4.88
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factors. Circulation (2009) 2.41
Breast cancer chemoprevention: old and new approaches. J Biomed Biotechnol (2012) 1.57
Reduced incidence of invasive breast cancer with raloxifene among women at increased coronary risk. J Natl Cancer Inst (2008) 1.56
Adverse reactions and drug-drug interactions in the management of women with postmenopausal osteoporosis. Calcif Tissue Int (2011) 1.50
Effect of raloxifene on stroke and venous thromboembolism according to subgroups in postmenopausal women at increased risk of coronary heart disease. Stroke (2008) 0.97
RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk. J Bone Miner Res (2014) 0.85
Emerging principles for the development of resistance to antihormonal therapy: implications for the clinical utility of fulvestrant. J Steroid Biochem Mol Biol (2006) 0.84
Experimental benefits of sex hormones on vascular function and the outcome of hormone therapy in cardiovascular disease. Curr Cardiol Rev (2008) 0.81
Long-term prospective study of the influence of estrone levels on events in postmenopausal women with or at high risk for coronary artery disease. ScientificWorldJournal (2012) 0.80
Correlation of bone mineral density with biochemical markers in post menopausal women. Indian J Clin Biochem (2009) 0.79
Estrogens and Stroke: Use of Oral Contraceptives and Postmenopausal Use of Estrogen: Current Recommendations. Curr Treat Options Neurol (2004) 0.79
Safety and effectiveness profile of raloxifene in long-term, prospective, postmarketing surveillance. J Bone Miner Metab (2012) 0.78
Selective estrogen receptor modulation influences atherosclerotic plaque composition in a rabbit menopause model. Atherosclerosis (2008) 0.77
Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med (2001) 27.70
Effect of alendronate on risk of fracture in women with low bone density but without vertebral fractures: results from the Fracture Intervention Trial. JAMA (1999) 11.23
Defective intracellular transport and processing of CFTR is the molecular basis of most cystic fibrosis. Cell (1990) 9.21
9-(2-hydroxyethoxymethyl) guanine activity against viruses of the herpes group. Nature (1978) 9.21
Left ventricular pseudoaneurysm. J Am Coll Cardiol (1998) 8.81
More is different. Science (1972) 7.93
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Efficacy of screening mammography. A meta-analysis. JAMA (1995) 6.94
Incidence of and treatment for ductal carcinoma in situ of the breast. JAMA (1996) 6.53
Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. J Am Coll Cardiol (1986) 6.27
Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst (2003) 6.20
Central obesity and increased risk of dementia more than three decades later. Neurology (2008) 6.03
Demonstration that CFTR is a chloride channel by alteration of its anion selectivity. Science (1991) 5.82
Chromosome 4q DNA rearrangements associated with facioscapulohumeral muscular dystrophy. Nat Genet (1992) 5.12
Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA (1996) 4.89
The nonvalue of sputum culture in the diagnosis of pneumococcal pneumonia. Am Rev Respir Dis (1971) 4.88
Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2000) 4.29
Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells. Nature (1990) 4.26
Ability of clinical laboratories to detect antimicrobial agent-resistant enterococci. J Clin Microbiol (1993) 4.25
Urinary incontinence: does it increase risk for falls and fractures? Study of Osteoporotic Fractures Research Group. J Am Geriatr Soc (2000) 4.05
Differences between respondents and non-respondents in a population-based cardiovascular disease study. Am J Epidemiol (1978) 3.90
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
The Resonating Valence Bond State in La2CuO4 and Superconductivity. Science (1987) 3.70
Suppressor thymus-derived lymphocytes in fungal infection. J Clin Invest (1976) 3.65
Should we be measuring blood cholesterol levels in young adults? JAMA (1993) 3.57
Beneficial effect of oestrogen on exercise-induced myocardial ischaemia in women with coronary artery disease. Lancet (1993) 3.56
Adding heparin to aspirin reduces the incidence of myocardial infarction and death in patients with unstable angina. A meta-analysis. JAMA (1996) 3.54
Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study. Circulation (1987) 3.49
Diabetes, impaired fasting glucose, and development of cognitive impairment in older women. Neurology (2004) 3.47
Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine (Baltimore) (1971) 3.40
Changes in the pharmacokinetics of ciprofloxacin and fecal flora during administration of a 7-day course to human volunteers. Antimicrob Agents Chemother (1984) 3.35
Endovaginal ultrasound to exclude endometrial cancer and other endometrial abnormalities. JAMA (1998) 3.32
Prevalence of urinary incontinence and associated risk factors in postmenopausal women. Heart & Estrogen/Progestin Replacement Study (HERS) Research Group. Obstet Gynecol (1999) 3.19
Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease. Am J Kidney Dis (1998) 3.09
Germline transformation of the silkworm Bombyx mori L. using a piggyBac transposon-derived vector. Nat Biotechnol (2000) 3.09
Expression and characterization of the cystic fibrosis transmembrane conductance regulator. Nature (1990) 3.09
Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System. J Natl Cancer Inst (1998) 3.08
A mutation in PRKAG3 associated with excess glycogen content in pig skeletal muscle. Science (2000) 3.06
Positive predictive value of screening mammography by age and family history of breast cancer. JAMA (1993) 2.95
Hysterectomy and urinary incontinence: a systematic review. Lancet (2000) 2.89
Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol (1995) 2.89
The prevalence of peripheral arterial disease in a defined population. Circulation (1985) 2.88
Cognitive decline in women in relation to non-protein-bound oestradiol concentrations. Lancet (2000) 2.82
Hormone replacement therapy and cardiovascular disease: a statement for healthcare professionals from the American Heart Association. Circulation (2001) 2.80
Latent and chronic infections imported from Southeast Asia. JAMA (1978) 2.78
WHSC1, a 90 kb SET domain-containing gene, expressed in early development and homologous to a Drosophila dysmorphy gene maps in the Wolf-Hirschhorn syndrome critical region and is fused to IgH in t(4;14) multiple myeloma. Hum Mol Genet (1998) 2.77
Interim report and recommendations of the World Health Organization Task-Force for Osteoporosis. Osteoporos Int (1999) 2.70
Antibiotics in chronic obstructive pulmonary disease exacerbations. A meta-analysis. JAMA (1995) 2.69
Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women. JAMA (1998) 2.64
Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet (1985) 2.62
Analysis of the tandem repeat locus D4Z4 associated with facioscapulohumeral muscular dystrophy. Hum Mol Genet (1994) 2.60
The epidemiology of head injury: a prospective study of an entire community-San Diego County, California, 1978. Am J Epidemiol (1981) 2.58
Estrogen use and all-cause mortality. Preliminary results from the Lipid Research Clinics Program Follow-Up Study. JAMA (1983) 2.57
The effect of teriparatide [human parathyroid hormone (1-34)] therapy on bone density in men with osteoporosis. J Bone Miner Res (2003) 2.50
Cholesterol and heart disease in older persons and women. Review of an NHLBI workshop. Ann Epidemiol (1994) 2.50
Likelihood ratios for modern screening mammography. Risk of breast cancer based on age and mammographic interpretation. JAMA (1996) 2.44
Growth hormone replacement in healthy older men improves body composition but not functional ability. Ann Intern Med (1996) 2.36
Effect of postmenopausal hormones on inflammation-sensitive proteins: the Postmenopausal Estrogen/Progestin Interventions (PEPI) Study. Circulation (1999) 2.31
Exercise patterns in a population of older adults. Am J Prev Med (1989) 2.28
Maturation and function of cystic fibrosis transmembrane conductance regulator variants bearing mutations in putative nucleotide-binding domains 1 and 2. Mol Cell Biol (1991) 2.25
Estrogen hits the surface. Nat Med (1999) 2.24
Hypothesis: inhibition of endothelium-derived relaxing factor by haemoglobin in the pathogenesis of pre-eclampsia. Lancet (1990) 2.24
The effect of age and bone mineral density on the absolute, excess, and relative risk of fracture in postmenopausal women aged 50-99: results from the National Osteoporosis Risk Assessment (NORA). Osteoporos Int (2006) 2.24
Belgian heart disease prevention project: incidence and mortality results. Lancet (1983) 2.23
Importance of carbon dioxide in the isolation of pneumococci. J Bacteriol (1966) 2.21
Meta-analysis of exercise testing to detect coronary artery disease in women. Am J Cardiol (1999) 2.20
Circulating sex hormones and breast cancer risk factors in postmenopausal women: reanalysis of 13 studies. Br J Cancer (2011) 2.20
Thymus medulla consisting of epithelial islets each derived from a single progenitor. Nature (2001) 2.18
A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease. N Engl J Med (1986) 2.18
Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group. Circulation (1997) 2.17
Retest reliability of plasma cholesterol and triglyceride. The Lipid Research Clinics Prevalence Study. Am J Epidemiol (1982) 2.15
Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA (1998) 2.14
Cognitive and functional status of the oldest old. J Am Geriatr Soc (1996) 2.14
Effects of passive smoking on ischemic heart disease mortality of nonsmokers. A prospective study. Am J Epidemiol (1985) 2.12
Postmenopausal hormone therapy and risk of stroke: The Heart and Estrogen-progestin Replacement Study (HERS). Circulation (2001) 2.12
The photosensitivity dermatitis and actinic reticuloid syndrome (chronic actinic dermatitis) occurring in seven young atopic dermatitis patients. Br J Dermatol (1998) 2.10
Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol (1996) 2.09
Impaired glucose tolerance in first-episode drug-naïve patients with schizophrenia. Diabet Med (2007) 2.06
Epidemiology of insulin-like growth factor-I in elderly men and women. The Rancho Bernardo Study. Am J Epidemiol (1997) 2.06
Low levels of protein C are associated with poor outcome in severe sepsis. Chest (2001) 2.05
A prospective population-based study of alcohol use and non-insulin-dependent diabetes mellitus. Am J Epidemiol (1990) 2.05
Dietary calcium and risk of hip fracture: 14-year prospective population study. Lancet (1988) 2.05
The effect of parity on the later development of non-insulin-dependent diabetes mellitus or impaired glucose tolerance. N Engl J Med (1989) 2.03
Neural network assessment of perioperative cardiac risk in vascular surgery patients. Med Decis Making (1998) 2.03
Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study. J Bone Miner Res (1997) 2.03
Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J (1997) 2.02
Mood, personality, and self-monitoring: negative affect and emotionality in relation to frontal lobe mechanisms of error monitoring. J Exp Psychol Gen (2000) 2.01
A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem (1997) 1.99
A prospective study of alcohol consumption and bone mineral density. BMJ (1993) 1.99
Assessment of quality of life in clinical trials of cardiovascular therapies. Am J Cardiol (1984) 1.99
Relative potencies of anti-herpes compounds. Ann N Y Acad Sci (1977) 1.98
Depressive symptoms in overweight and obese older adults: a test of the "jolly fat" hypothesis. J Psychosom Res (1996) 1.97
Safety and dose relationship of recombinant human activated protein C for coagulopathy in severe sepsis. Crit Care Med (2001) 1.97